Magnetic stimulation in the diagnosis of diseases of central and peripheral nervous system

Cognitive impairment in post-stroke patients is often a major cause of social limitations. They seem insignificant and are masked by prominent post-stroke motor disorders, but negatively affect rehabilitation outcomes with loss of learning skills. Application of transcranial magnetic stimulation using multiple variations of schemes, its feature of noninvasive influence on the central and peripheral nervous system and modification of plasticity processes, appears effective for therapy in post-stroke patients, both in the acute and recovery periods.

Download Full-text

Magnetic stimulation of the central and peripheral nervous system: Evaluation in healthy controls and patients with various neurological disorders

Electroencephalography and Clinical Neurophysiology ◽

10.1016/0013-4694(93)91326-v ◽

1993 ◽

Vol 87 (2) ◽

pp. S101

Author(s):

S. Mochio ◽

H. Oka ◽

A. Kurita ◽

T. Hasunuma ◽

K. Sato ◽

...

Keyword(s):

Nervous System ◽

Peripheral Nervous System ◽

Neurological Disorders ◽

Magnetic Stimulation ◽

System Evaluation ◽

Healthy Controls ◽

Stimulation Of

Download Full-text

Magnetic stimulation of the human brain and peripheral nervous system

Neurosurgery ◽

10.1097/00006123-198701000-00024 ◽

1987 ◽

Vol 20 (1) ◽

pp. 100???9 ◽

Cited By ~ 362

Author(s):

A T Barker ◽

I L Freeston ◽

R Jalinous ◽

J A Jarratt

Keyword(s):

Nervous System ◽

Human Brain ◽

Peripheral Nervous System ◽

Magnetic Stimulation ◽

Stimulation Of

Download Full-text

Glucuronyl 3-sulfate occurs exclusively on distal unmyelinated terminals of selected sensory neurons in the peripheral nervous system

Proceedings, annual meeting, Electron Microscopy Society of America ◽

10.1017/s0424820100141160 ◽

1995 ◽

Vol 53 ◽

pp. 958-959

Author(s):

S.S. Spicer ◽

B.A. Schulte

Keyword(s):

Central Nervous System ◽

Nervous System ◽

Cerebral Cortex ◽

Peripheral Nervous System ◽

Sensory Neurons ◽

Sensory Nerves ◽

Tissue Antigens ◽

The Central Nervous System ◽

The Brain ◽

Leu 7

Generation of monoclonal antibodies (MAbs) against tissue antigens has yielded several (VC1.1, HNK- 1, L2, 4F4 and anti-leu 7) which recognize the unique sugar epitope, glucuronyl 3-sulfate (Glc A3- SO4). In the central nervous system, these MAbs have demonstrated Glc A3-SO4 at the surface of neurons in the cerebral cortex, the cerebellum, the retina and other widespread regions of the brain.Here we describe the distribution of Glc A3-SO4 in the peripheral nervous system as determined by immunostaining with a MAb (VC 1.1) developed against antigen in the cat visual cortex. Outside the central nervous system, immunoreactivity was observed only in peripheral terminals of selected sensory nerves conducting transduction signals for touch, hearing, balance and taste. On the glassy membrane of the sinus hair in murine nasal skin, just deep to the ringwurt, VC 1.1 delineated an intensely stained, plaque-like area (Fig. 1). This previously unrecognized structure of the nasal vibrissae presumably serves as a tactile end organ and to our knowledge is not demonstrable by means other than its selective immunopositivity with VC1.1 and its appearance as a densely fibrillar area in H&E stained sections.

Download Full-text

Stimulating Swallowing: Essential Central and Peripheral Nervous System Targets

ASHA Leader ◽

10.1044/leader.ftr1.16092011.10 ◽

2011 ◽

Vol 16 (9) ◽

pp. 10-13 ◽

Cited By ~ 3

Author(s):

Ianessa A. Humbert

Keyword(s):

Nervous System ◽

Peripheral Nervous System

Download Full-text

Questions and Answers

Guides Newsletter ◽

10.1001/amaguidesnewsletters.2000.marapr02 ◽

2000 ◽

Vol 5 (2) ◽

pp. 3-3

Author(s):

Christopher R. Brigham ◽

James B. Talmage

Keyword(s):

Nervous System ◽

Peripheral Nervous System ◽

Spinal Nerve ◽

Sensory Loss ◽

Residual Symptoms ◽

Additional Information ◽

Questions And Answers ◽

Motor Nerves ◽

Symptoms And Signs ◽

Limited Motion

Abstract Lesions of the peripheral nervous system (PNS), whether due to injury or illness, commonly result in residual symptoms and signs and, hence, permanent impairment. The AMA Guides to the Evaluation of Permanent Impairment (AMA Guides) describes procedures for rating upper extremity neural deficits in Chapter 3, The Musculoskeletal System, section 3.1k; Chapter 4, The Nervous System, section 4.4 provides additional information and an example. The AMA Guides also divides PNS deficits into sensory and motor and includes pain within the former. The impairment estimates take into account typical manifestations such as limited motion, atrophy, and reflex, trophic, and vasomotor deficits. Lesions of the peripheral nervous system may result in diminished sensation (anesthesia or hypesthesia), abnormal sensation (dysesthesia or paresthesia), or increased sensation (hyperesthesia). Lesions of motor nerves can result in weakness or paralysis of the muscles innervated. Spinal nerve deficits are identified by sensory loss or pain in the dermatome or weakness in the myotome supplied. The steps in estimating brachial plexus impairment are similar to those for spinal and peripheral nerves. Evaluators should take care not to rate the same impairment twice, eg, rating weakness resulting from a peripheral nerve injury and the joss of joint motion due to that weakness.

Download Full-text